atopic dermatitis
Conditions
Interventions
Subjects apply study drug twice a day for four weeks.
Subjects visit a hospital for treatment in application first day, application one week later, two weeks later and four weeks later.
In the visitin
Sponsors
Higuchi Ayako
Kawashima Makoto
Miyachi Yoshiki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The atopic dermatitis patients that remission maintenance is possible just to use a moisturizer for a whole body (Include the patients who use the external preparation for anti-inflammatory for a part of the whole body). 2) The patients who continues remission maintenance more than four weeks. 3) The patients who have a skin drying part. 4) The patients aged 20-49 at consent. 5) The patients with written consent about this study entry.
Exclusion criteria
Exclusion criteria: 1) Subjects who have the skin disease except the target disease and other diseases that it is thought that the diseases affect this study. 2) Subjects who have the injury that it is thought that the diseases affect this study or exanthem is the one in the observation part. 3) Subjects who is thought that the drug (systemic steroid, immunosuppressive drug, dupilumab preparation, et al) to influence on this study is necessary within four weeks before study start or in future. 4) Subjects who have the contact dermatitis with the past for cosmetics. 5) Pregnant or possibly pregnant women, breastfeeding women, or women who wish to become pregnant during study participation. 6) Subjects who participated in other clinical studies in the past 3 months. 7) In addition, subjects that it is judged by responsible doctor that participation in final examination is inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The skin drying findings (drying, scale, desquamation) by the dermatologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Change over time of the itch score. 2) The skin measurement by device ( corner layer water content, transepidermal water loss ). 3) Tape stripping (lipid analysis, cytokine analysis). 4) Photography. 5) The use situation of the study drug. 6) Questionary survey. | — |
Contacts
Public ContactYasunari Hiramatsu
NPO Health Institute Research of Skin
Outcome results
None listed